| 000 | 01438nam a2200313 a 4500 | ||
|---|---|---|---|
| 005 | 20250918143906.0 | ||
| 008 | 110815s2010 xxua 001 0 eng | ||
| 020 |
_a9780309151290 (pbk.) _cRM134.40 |
||
| 039 | 9 |
_a201111191534 _bzaleha _c201111141559 _djamal _c201111141533 _dIzzati _y08-15-2011 _zIzzati |
|
| 040 | _dUKM | ||
| 060 |
_aQW541 _b.E917 2010 9HUKM |
||
| 090 | _aQW541.E917 2010 9HUKM | ||
| 245 | 0 | 0 |
_aEvaluation of biomarkers and surrogate endpoints in chronic disease / _cCommittee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editors. |
| 260 |
_aWashington, D. C. : _bNational Academies Press, _c2010. |
||
| 300 |
_axx, 314 p. : _bill. ; _c23 cm. |
||
| 650 | 2 | _aBiological Markers | |
| 650 | 2 | _aChronic Disease | |
| 650 | 2 | _aEvidence-Based Practice | |
| 700 | 1 | _aMicheel, Christine M. | |
| 700 | 1 |
_aBall, John R., _d1944- |
|
| 710 | 2 |
_aInstitute of Medicine (U.S.). _bCommittee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease. |
|
| 907 |
_a.b15133746 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQW541.E917 2010 9HUKM |
||
| 914 | _avtls003476282 | ||
| 990 | _aizzati/zaleha | ||
| 991 | _aInstitut Perubatan Molekul (UMBI) | ||
| 998 |
_ah _b2011-02-08 _cm _da _feng _gxxu _y0 _z.b15133746 |
||
| 999 |
_c497667 _d497667 |
||